LD-2 disclosure · 1st Quarter - Report
ELI LILLY & COMPANY
Client
- Description
- Pharmaceutical/ Health Products
- Location
- District of Columbia · United States of America
Registrant
- Description
- Lobbying Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
7 issuesTaxation/Internal Revenue Code
International and domestic tax issues. Implementation of PL 119-21.
LobbyistsSUSAN HIRSCHMANN · mr CHRISTOPHER W HATCHER · mr MATTHEW B HOEKSTRA · JEANNE HAGGERTY
Covered position (JEANNE HAGGERTY): Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
340B Drug Pricing program, pharmaceutical supply chain, drug compounding and counterfeiting issues, PBM reform policies.
LobbyistsSUSAN HIRSCHMANN · ms MELINDA M MAXFIELD · mr MATTHEW B HOEKSTRA · CHRISTOPHER E. WILCOX · JEANNE HAGGERTY · ROBERT BUTORA
Covered position (CHRISTOPHER E. WILCOX): LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings
Covered position (JEANNE HAGGERTY): Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
Covered position (ROBERT BUTORA): Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess